MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Home » Alphatec to purchase EOS Imaging

Alphatec to purchase EOS Imaging

By

AlphatecAlphatec (NSDQ:ATEC) today said it would acquire EOS Imaging for $88 million, plus debt retirement of $33.9 million.

EOS Imaging develops rapid, low dose, biplanar, full-body imaging and 3D modeling capabilities. It captures a calibrated, full-body image in a standing position, offering precise measurement of anatomical angles and dimensions.

“This is a monumental transaction for ATEC,” CEO Pat Miles said in a news release. “While spine’s large players are investing in enabling technologies, we are thinking differently. We created a conduit to deliver information into the operating room with AlphaInformatiX. This transaction will integrate spine imaging and anatomical modeling onto the platform to actually inform the operative experience. By paring ATEC’s approach-based solutions with imaging founded on Nobel Prize-winning technology, we expect to significantly increase demand for ATEC hardware and EOS systems and create a formidable competitive advantage.”

The transaction is expected to expand Alphatec’s revenue base through EOS’s revenue run rate. The company expects the acquisition to be accretive to revenue, revenue growth, adjusted EBITDA and free cash flow in its first full year of operations.

“EOS is a fabulous, game-changing technology that has unquestionably improved the treatment of children, adolescents and adults with spinal deformity,” Christopher Shaffrey, chief of spinal surgery and spine care at Duke University Medical Center, said.

The Boards of Directors at both companies have approved the transaction. Alphatec will launch a tender offer for all issued and outstanding shares and convertible notes of EOS Imaging for a total purchase price of up to $122 million. The offer will consist of a cash tender offer price of €2.80 per EOS share, or at the option of each EOS shareholder, an exchange tender offer where each shareholder will receive 0.5 ATEC common shares per one EOS share.

“We are very enthusiastic about the opportunity to join the complementary strengths and know-how of EOS imaging and ATEC,” CEO of EOS Imaging Mike Lobinsky said. “I have no dory that our organizations will be able to quickly create a highly differentiated end-to-end offering that will accelerate growth in the U.S> in the short term, while we continue to expand internationally, paving the way for the future global growth of the combined entity.”

In case you missed it

RSS From Medical Design & Outsourcing

  • How COVID-19 changed medical device clinical trials forever
    The success of remote clinical trial oversight opens the door to hybrid approaches and creates new possibilities for the future of trials. DeviceTalks Because of the pandemic, virtually overnight, all players involved in medical device clinical trials had to pivot to virtual monitoring to keep trials going. What impact did remote trial oversight have on… […]
  • Nuvasive launches ALIF 3D printed porous titanium implant
    Nuvasive this week announced that it has launched its Modulus ALIF 3D printed porous titanium implant for anterior lumbar interbody fusion. San Diego-based Nuvasive designed Modulus for enhanced osseointegration, according to the company. It has a porous surface architecture engineered for fusion and promotes new bone on-growth and in-growth. The design also allows for enhanced… […]
  • Cardinal Health subsidiary faces federal lawsuit over EtO plant in Georgia
    Nearly two dozen people who have lived in the Augusta, Ga. area are suing Cardinal Health subsidiary Kendall Patient Recovery U.S. over ethylene oxide emissions from a medical device sterilization plant in the city. The people suing KPR U.S. in U.S. District Court in Southern Georgia lived and worked within miles of the Augusta facility… […]
  • FDA seeks expanded authority to boost medical device supply chain
    The FDA announced as part of its annual budget proposal that it will include $21.6 million for a new Resilient Supply Chain and Shortages Prevention Program (RSCSPP). Funding from the RSCSPP for the Center for Devices and Radiological Health (CDRH) will provide — the FDA says, for the first time — resources to establish a… […]
  • Using RVI to prevent contamination and maintain purity of pharmaceuticals 
    Here’s how remote visual inspection (RVI) can help pharma companies prevent contamination and maintain product-line purity requirements. Hafees Fraisada, Olympus Bacterial or foreign-particle contamination in production-line equipment can cause serious health issues for consumers and shake public confidence in the industry. Strict purity and contamination control of pharmaceutical manufacturing facilities is required under various international… […]
  • The 18 most innovative medical devices of 2021
    The Galien Foundation today announced the nominees for most innovative medical devices for its 15th annual Prix Galien USA Awards. The foundation nominates devices, biotechnology and pharmaceutical products for its annual Prix Galien awards to highlight products designed to improve the human condition. “The Awards Committee is excited to introduce the nominees for the 2021… […]
  • Stäubli Robotics appoints new pharma and medical device head
    The mechatronics and robotics company Stäubli (Pfäffikon, Switzerland) has named Olivier Cremoux to be the deputy head of pharma and medical device for Stäubli Robotics North America. Cremoux has worked in various Stäubli divisions since 2015 and has served as an international business development manager. In 2018, he began a stint as a North American… […]
  • Novanta acquires ATI Industrial Automation and its surgical robotics tech
    Novanta today announced that it has agreed to acquire ATI Industrial Automation for $172 million in cash. Bedford, Mass.–based Novanta plans to acquire the OEM surgical robotics supplier for $172 million upfront in cash and additional contingent cash payments associated with company financial performance in 2021. The company will also grant performance stock units. ATI… […]
  • Dexcom CEO Kevin Sayer says G7 will be ‘wonderful’
    As we enter what may be the “new normal,” Dexcom’s CEO bets the company can pave the way in continuous glucose monitoring. Dexcom (NSDQ:DXCM), like any company seeking to innovate, remains in a state of perpetual forward motion. That’s the way chair, president & CEO Kevin Sayer views it, anyway. As the company looks toward the… […]
  • How to better clean fiber optics in medical devices
    When it comes to fiber optics in medical devices, cleaning is essential for reliability. Jay Tourigny, MicroCare The use of fiber optics in the medical industry is steadily increasing. As the population continues to grow and age, healthcare providers are using fiber optic devices for better patient diagnosis, monitoring and treatment. Today fiber optics are… […]
  • 7 ways to ensure your medical device product design isn’t biased
    Correcting unintentional biases in medical device product design is a big step toward improving equity in medtech. Achuta Kadambi, an assistant professor at the UCLA Samueli School of Engineering, says when looking at bias in medical devices, there’s often a lot of narrative in the media of what it is. However, it’s also important to… […]